-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$19.38-0.97% Downside
Catalyst Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. has been rated by research analysts at Truist Financial, H.C. Wainwright, Piper Sandler, Roth Capital in the past 90 days.